|
summary: The authors looked at which clinical parameters predict a poor response to Interferon-beta and found that a high degree of disability at the beginning of treatment and incomplete relapse suppression during treatment were predictive.
authors: O'rourke K, Walsh C, Antonelli G, Hutchinson M.
source: Mult Scler. 2007 May;13(3):336-42
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Beta-interferon
Disability
Immunosuppressio
Interferon
Multiple sclerosis
Relapse
Relapsing/remitting MS
Sclerosis
|